Respiratory Dyskinesia With Refractory Tachypnea and Alkalosis Treated by Vesicular Monoamine Transporter 2 Inhibitor. [PDF]
Wu YJ, He Q, Luo FG, Li T, Guo WJ.
europepmc +1 more source
Preclinical Catecholaminergic Biomarkers of Central Lewy Body Diseases. [PDF]
Goldstein DS.
europepmc +1 more source
Disruption of Dopamine Homeostasis by Psychostimulants. [PDF]
Torres J +3 more
europepmc +1 more source
VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1-linked Parkinson's neurons. [PDF]
Heger LM +14 more
europepmc +1 more source
Reimagining biogenic amine signaling in the brain and beyond. [PDF]
Vinson DA, Maze I.
europepmc +1 more source
Physiological implications of phase separation in vesicle organization and trafficking. [PDF]
Liu C, Cheng J, Wu X.
europepmc +1 more source
Expression and Diagnostic Significance of Clinical Routine VMAT2 Immunostaining in Neuroendocrine Neoplasia: A Study of Institutional Cases. [PDF]
Ankers Z, Hellgren LS, Juhlin CC.
europepmc +1 more source
A comparative exploration of monoamine neurotransmitter transport disorders: mechanisms, clinical manifestations, and therapeutic approaches. [PDF]
Al Sari RR +9 more
europepmc +1 more source
Sex-differences in catecholamine transporter expression in the rodent prefrontal cortex following repetitive mild traumatic brain injury and methylphenidate treatment. [PDF]
Papadopoulos E +5 more
europepmc +1 more source
Compartment-Specific Mitochondrial Proteomic Alterations in Rat Hippocampus Following Chronic Social Isolation Stress. [PDF]
Filipović D.
europepmc +1 more source

